Puro Risk Insights Blog
Our blog is an educational hub for clear and timely insights on the cannabis and hemp industry.
We simplify insurance topics regulatory updates and real world risks into easy to understand content for operators at every stage.
From cultivation to retail we provide practical guidance coverage education and market insights to help you stay compliant protected and informed so you can make smarter and more confident decisions.
ON THE BLOG
CATEGORIES
FEATURED POST
Recent Industry Updates
All Articles
Browse our complete collection of cannabis and hemp insights below. This page brings together all published articles covering policy and regulation, business and economy, legal and justice, industry innovation, and culture and community. Each post is created to educate and inform operators and industry stakeholders by breaking down complex topics into clear, practical insights. Scroll down to explore the full library and stay informed on the issues shaping the industry.
Missouri Cracks Down on Hemp-Derived THC Beverages as Market Booms
Missouri regulators are preparing enforcement actions against the state’s booming hemp-derived THC beverage market, which is projected to grow 25% in 2025. As federal oversight remains unclear, Missouri joins other states in tightening control to protect consumers and ensure market integrity.
37 State Attorneys General Call for Federal Ban on Hemp-Derived THC
Thirty-seven state attorneys general have urged Congress to ban hemp-derived THC products, citing health and enforcement concerns. Their unified call for federal action could reshape the future of hemp regulation — and impact every operator in the space.
Pennsylvania Moves Toward a Cannabis Control Board
Pennsylvania lawmakers advanced a bill to create a Cannabis Control Board that would oversee both medical marijuana and hemp-derived products. The move emphasizes regulatory reform and consumer safety, not adult-use legalization — but it could set the stage for a more unified and professional cannabis framework.
Cannabis Stocks to Watch: Tilray, Canopy Growth, and Greenlane Gain Momentum
Cannabis stocks like Tilray, Canopy Growth, and Greenlane are seeing renewed investor attention thanks to increased trading volume and optimism around policy reform. Here’s what’s driving the resurgence — and what it means for the future of cannabis business and investment.
MariMed Expands Into New York’s $6 Billion Cannabis Market
Massachusetts-based MariMed is expanding into New York through a licensing partnership with Farm 2 Hand LLC, giving it access to the state’s $6 billion adult-use cannabis market. The deal highlights the growing trend of compliance-focused brand licensing as a key strategy for national cannabis growth.
Cannabis Moves Closer to Mainstream Medicine
The American Council of Cannabis Medicine is partnering with insurers, health systems, and wellness organizations to expand medically guided cannabis access. This collaboration marks a major step toward integrating cannabis into mainstream healthcare and reshaping how patients receive treatment.
West Virginia’s Cannabis Revenue Sits Idle: $34 Million Unspent
West Virginia’s medical cannabis program has generated nearly $34 million in taxes and fees since 2021 — yet none of it has been spent. As the state’s funds sit idle, patients and operators are left wondering when the benefits of legalization will finally reach communities in need.
Los Angeles Faces a $400 Million Cannabis Tax Problem
Two-thirds of licensed cannabis businesses in Los Angeles owe nearly $400 million in unpaid taxes, forcing the city to consider a tax amnesty program. The shortfall exposes deeper challenges facing California’s cannabis industry — from over-taxation to compliance fatigue.
New York’s “Rent-a-License” Scandal Exposes Gaps in Cannabis Compliance
New York regulators have charged Omnium Canna with allegedly allowing unlicensed operators to manufacture and package cannabis under its license. The “rent-a-license” case exposes serious weaknesses in the state’s track-and-trace system and highlights why compliance and risk management are critical for cannabis operators.
Massachusetts Faces a Push to Repeal Adult-Use Cannabis
Massachusetts cannabis advocates are fighting to keep the state’s $1.6 billion market alive as a repeal campaign gains momentum for the 2026 ballot. The outcome could redefine legalization not only in Massachusetts but across the country — and serve as a wake-up call for cannabis operators to prepare for regulatory risk.
Disclaimer: All content on this site is for informational and educational purposes only. We share news, insights, and our own interpretations but do not claim ownership of third-party content, always crediting original sources with links. Views expressed in shared content do not necessarily reflect our own. For accurate and current information, please consult the original publisher.
Ready to review your cannabis coverage?
Call us on (323)905-3396
or growth@cannashield.io

Trulieve and Cronos have each gained roughly 27 percent in 2026 while reporting stronger operating results. The broader signal is that public market attention is increasingly rewarding cash generation, improving margins, liquidity, and measurable revenue growth.